跳至主要内容
临床试验/NCT03708666
NCT03708666已完成不适用

Nephrocare mHealth: Improvement of Patient Empowerment and Self-management by the Use of Telemonitoring.

Universitaire Ziekenhuizen KU Leuven1 个研究点 分布在 1 个国家目标入组 79 人开始时间: 2017年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
79
试验地点
1
主要终点
Systolic and diastolic blood pressure under control

研究概览

简要总结

The Nephrocare mHealth project supports patients with Chronic Kidney Disease with a mobile application and telemonitoring. The application includes the follow-up of blood pressure.

详细描述

Patients that are included in the Nephrocare mHealth project send their blood pressure results through an app or online website.

The clinical decision support system will alert the patient, as well as the general practitioner and the hospital when the blood pressure is too high or low. In addition the clinical decision support will calculate monthly averages and all the data are connected with the electronic patient files.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Dutch-speaking
  • •Signed and approved informed consent
  • •Follow-up by nephrology at the University Hospitals Leuven or General Hospital Groeninge

排除标准

  • •No Dutch-speaking
  • •Impaired cognitive condition or medically unstable

研究组 & 干预措施

Telemonitoring of blood pressure

Other

Patients measure their blood pressure and register their results on the app or website.

干预措施: Telemonitoring of blood pressure (Other)

结局指标

主要结局

Systolic and diastolic blood pressure under control

时间窗: 6 months

Percentage of patients with blood pressure within target limits

次要结局

  • Adaptations of treatment(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kathleen Claes

Prof. Dr. K. Claes

Universitaire Ziekenhuizen KU Leuven

研究点 (1)

Loading locations...

相似试验